Compare Box Inc (BOX) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Box Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Box Inc trades at $29.3 (market cap $4.07B), while Regeneron Pharmaceuticals Inc trades at $655.5 (market cap $69.52B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 17.1× Box Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.57% dividend while Box Inc pays none. Which is the better fit depends on your goals.
| BOX | REGN | |
|---|---|---|
Market Cap | $4.07B | $69.52B |
Sector | Technology | Health |
52-Week High | $33.55 | $812.27 |
52-Week Low | $21.37 | $542.52 |
Enterprise Value | $4.62B | $63.47B |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Box Inc
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature that enhance workflow management and collaboration.
Read more on BOX →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
